TA
RCUS icon

Teachers Advisors’s Arcus Biosciences RCUS Stock Holding History

Teachers Advisors’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$888K Buy
71,094
+7,153
+11% +$77.6K ﹤0.01% 2342
2018
Q4 		$689K Buy
63,941
+51,171
+401% +$597K ﹤0.01% 2367
2018
Q3 		$178K Buy
+12,770
New +$163K ﹤0.01% 2958

Other funds holding RCUS

AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
PS
Peter Svennilson $1.23B AUM 301.34% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FCMI
Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Teachers Advisors's RCUS Position: Q1 2019 in Review

Teachers Advisors increased its Arcus Biosciences (RCUS) stake by 11% in Q1 2019, buying an estimated $77.6K and bringing the position to 71,094 shares worth $888K. The position accounts for ﹤0.01% of the portfolio, ranked #2342.

Teachers Advisors first reported a position in RCUS in Q3 2018 and has held it in 3 quarters since. 64 funds tracked by Wall St. Rank hold RCUS as of Q1 2019.

  • Teachers Advisors held 71,094 shares of Arcus Biosciences worth $888K as of Q1 2019.
  • Teachers Advisors bought 7,153 Arcus Biosciences shares in Q1 2019, an estimated $77.6K.
  • Arcus Biosciences made up ﹤0.01% of Teachers Advisors's portfolio in Q1 2019, its #2342 holding.
  • Teachers Advisors first reported a position in Arcus Biosciences in Q3 2018 and has held it in 3 quarters since.
  • 64 funds tracked by Wall St. Rank held Arcus Biosciences as of Q1 2019.

Based on Teachers Advisors's 13F filing for Q1 2019, filed 14 May 2019.